TLR4 and cancer: It seems that the Toll-like receptor 4 (TLR4)/myeloid differentiation factor 88 (Myd88) signaling pathway is the major enhancer of the immunosuppressive activities of MDSCs and consequently induces immunosuppression, e.g., in conditions such as infections and cancers [93, 94].